INTEGRATED ANALYSIS OF HETEROGENEOUS COVID-19 DATASETS USING KNOWLEDGE GRAPH.
Award amount
$300,000Program and phase
SBIR · Phase IAward year
2021Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- Melax Technologies, Inc
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- ME3MA61LJD79
- Solicitation number
- PHS2021-1
- Topic code
- 100
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Clinical Decision Support System for Early Detection of Cognitive Decline Using Electronic Health Records and Deep Learning
- REAL-TIME SURVEILLANCE OF VACCINE MISINFORMATION FROM SOCIAL MEDIA PLATFORMS USING ONTOLOGY AND NATURAL LANGUAGE PROCESSING TECHNOLOGIES
- CLAMP-CS: a Cloud-based, Service-oriented, high-performance Natural Language Processing Platform for Healthcare
- SBIR PHASE I- TOPIC 410 - CANCER CLINICAL TRIALS RECRUITMENT AND RETENTION TOOLS FOR PARTICIPANT ENGAGEMENT.
- Developing informatics tools to make immunology research data Findable, Accessible, Interoperable and Reusable
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- First-in-class TREM-1 inhibitors for neovascular retinal diseases
- Development of a Novel Biosensor to Accelerate Investigations of the Gut Microbiome
- Magnetic Lipid Nanoprobe Platform for Rapid, Highly-Efficient, and Cost-Effective Isolation of Extracellular Vesicles from Non-Invasive Bodily Fluids
- Scale-up and Manufacturing of STLR-201, an off-the-shelf regenerative therapeutic for Sjogren's syndrome-related dry eye disease
- Integrated assays of single-cell dynamics and molecular phenotype for cell therapy manufacturing
Research funding history
6 SBIR/STTR records share this UEI (2018–2023). Reported award amounts total $3,721,442. Reported amounts are not federal obligations.
Phases: Phase I, Phase II – Direct to Phase II
Agencies: Department of Health and Human Services